Ketamine pills could ease debilitating CRPS pain – new trial underway

NCT ID NCT06419985

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This phase 2 trial will test whether extended-release ketamine tablets can reduce pain in 65 adults with complex regional pain syndrome (CRPS), a chronic condition causing severe, often burning pain. Participants will take either 80 mg or 160 mg of ketamine daily for several weeks. The study is open-label, meaning everyone knows they are getting the drug, and it focuses on pain scores, quality of life, and safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ketamine extended-release tablets
What this could lead to
If successful, this could provide a new oral treatment option to ease chronic pain for people with complex regional pain syndrome.
What could go wrong
This is an early-phase, open-label trial with no placebo group, so results may be influenced by expectation. The small size (65 people) also limits how broadly findings can be applied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLEX REGIONAL PAIN SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pain Center, Keck Medical Center of University of Southern California

    Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.